Filed: 11/14/2024ACC: 0001697013-24-000007
📋 What this filing means
EVERSEPT PARTNERS, LP filed this quarterly 13F‑HR report disclosing 67 equity positions with a total reported market value of $1.46B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
67
Positions
$1.46B
Total AUM (reported)
65.58M
Total Shares
Allocation by class
COM$833.66M57.1%
SPONSORED ADR$165.86M11.4%
UNIT SER 1$121.82M8.3%
CL A$90.62M6.2%
COM PAR $.01$79.53M5.4%
SPONSORED ADS$58.29M4.0%
COM NEW$35.61M2.4%
Portfolio Concentration
Top 3$398.15M27.3%
4–10$479.04M32.8%
11–25$401.26M27.5%
Rest$181.39M12.4%
Top 3 weight
27.3%
Top 10 weight
60.1%
Voting Authority Distribution
Total shares with voting rights: 65.58M
Sole
Full voting authority
65.58M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole67
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings67
Rows:
GSK PLC
SOLEShares4.06M
TypeSH
Market value$165.86M
11.36%
Sole
4.06M
Shared
0.00
None
0.00
INVESCO QQQ TR
SOLEShares249.60K
TypeSH
Market value$121.82M
8.34%
Sole
249.60K
Shared
0.00
None
0.00
NATERA INC
SOLEShares870.19K
TypeSH
Market value$110.47M
7.57%
Sole
870.19K
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares2.05M
TypeSH
Market value$90.62M
6.21%
Sole
2.05M
Shared
0.00
None
0.00
INSMED INC
SOLEShares1.09M
TypeSH
Market value$79.53M
5.45%
Sole
1.09M
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares4.11M
TypeSH
Market value$79.03M
5.41%
Sole
4.11M
Shared
0.00
None
0.00
REVVITY INC
SOLEShares469.69K
TypeSH
Market value$60.00M
4.11%
Sole
469.69K
Shared
0.00
None
0.00
INSPIRE MED SYS INC
SOLEShares276.27K
TypeSH
Market value$58.31M
3.99%
Sole
276.27K
Shared
0.00
None
0.00
TEVA PHARMACEUTICAL INDS LTD
SOLEShares3.23M
TypeSH
Market value$58.29M
3.99%
Sole
3.23M
Shared
0.00
None
0.00
COMMUNITY HEALTH SYS INC NEW
SOLEShares8.78M
TypeSH
Market value$53.27M
3.65%
Sole
8.78M
Shared
0.00
None
0.00
BIO-TECHNE CORP
SOLEShares663.57K
TypeSH
Market value$53.04M
3.63%
Sole
663.57K
Shared
0.00
None
0.00
HCA HEALTHCARE INC
SOLEShares129.08K
TypeSH
Market value$52.46M
3.59%
Sole
129.08K
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP DEL
SOLEShares130.95K
TypeSH
Market value$46.93M
3.21%
Sole
130.95K
Shared
0.00
None
0.00
SPDR S&P 500 ETF TR
SOLEShares60K
TypeSH
Market value$34.43M
2.36%
Sole
60K
Shared
0.00
None
0.00
ZIMVIE INC
SOLEShares2.07M
TypeSH
Market value$32.86M
2.25%
Sole
2.07M
Shared
0.00
None
0.00
HEALTHEQUITY INC
SOLEShares319.08K
TypeSH
Market value$26.12M
1.79%
Sole
319.08K
Shared
0.00
None
0.00
REPLIGEN CORP
SOLEShares163.59K
TypeSH
Market value$24.35M
1.67%
Sole
163.59K
Shared
0.00
None
0.00
VIATRIS INC
SOLEShares1.73M
TypeSH
Market value$20.04M
1.37%
Sole
1.73M
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares445.20K
TypeSH
Market value$20.03M
1.37%
Sole
445.20K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares564.90K
TypeSH
Market value$19.20M
1.32%
Sole
564.90K
Shared
0.00
None
0.00
IONIS PHARMACEUTICALS INC
SOLEShares471.36K
TypeSH
Market value$18.88M
1.29%
Sole
471.36K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares691.23K
TypeSH
Market value$15.73M
1.08%
Sole
691.23K
Shared
0.00
None
0.00
MANNKIND CORP
SOLEShares1.99M
TypeSH
Market value$12.53M
0.86%
Sole
1.99M
Shared
0.00
None
0.00
BAUSCH HEALTH COS INC
SOLEShares1.53M
TypeSH
Market value$12.49M
0.86%
Sole
1.53M
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares869.91K
TypeSH
Market value$12.17M
0.83%
Sole
869.91K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
GSK PLCSOLE | SPONSORED ADR | 4.06M | SH | $165.86M 11.36% | 4.06M | 0.00 | 0.00 |
INVESCO QQQ TRSOLE | UNIT SER 1 | 249.60K | SH | $121.82M 8.34% | 249.60K | 0.00 | 0.00 |
NATERA INCSOLE | COM | 870.19K | SH | $110.47M 7.57% | 870.19K | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | CL A | 2.05M | SH | $90.62M 6.21% | 2.05M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 1.09M | SH | $79.53M 5.45% | 1.09M | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 4.11M | SH | $79.03M 5.41% | 4.11M | 0.00 | 0.00 |
REVVITY INCSOLE | COM | 469.69K | SH | $60.00M 4.11% | 469.69K | 0.00 | 0.00 |
INSPIRE MED SYS INCSOLE | COM | 276.27K | SH | $58.31M 3.99% | 276.27K | 0.00 | 0.00 |
TEVA PHARMACEUTICAL INDS LTDSOLE | SPONSORED ADS | 3.23M | SH | $58.29M 3.99% | 3.23M | 0.00 | 0.00 |
COMMUNITY HEALTH SYS INC NEWSOLE | COM | 8.78M | SH | $53.27M 3.65% | 8.78M | 0.00 | 0.00 |
BIO-TECHNE CORPSOLE | COM | 663.57K | SH | $53.04M 3.63% | 663.57K | 0.00 | 0.00 |
HCA HEALTHCARE INCSOLE | COM | 129.08K | SH | $52.46M 3.59% | 129.08K | 0.00 | 0.00 |
UNITED THERAPEUTICS CORP DELSOLE | COM | 130.95K | SH | $46.93M 3.21% | 130.95K | 0.00 | 0.00 |
SPDR S&P 500 ETF TRSOLE | TR UNIT | 60K | SH | $34.43M 2.36% | 60K | 0.00 | 0.00 |
ZIMVIE INCSOLE | COM | 2.07M | SH | $32.86M 2.25% | 2.07M | 0.00 | 0.00 |
HEALTHEQUITY INCSOLE | COM | 319.08K | SH | $26.12M 1.79% | 319.08K | 0.00 | 0.00 |
REPLIGEN CORPSOLE | COM | 163.59K | SH | $24.35M 1.67% | 163.59K | 0.00 | 0.00 |
VIATRIS INCSOLE | COM | 1.73M | SH | $20.04M 1.37% | 1.73M | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 445.20K | SH | $20.03M 1.37% | 445.20K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 564.90K | SH | $19.20M 1.32% | 564.90K | 0.00 | 0.00 |
IONIS PHARMACEUTICALS INCSOLE | COM | 471.36K | SH | $18.88M 1.29% | 471.36K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 691.23K | SH | $15.73M 1.08% | 691.23K | 0.00 | 0.00 |
MANNKIND CORPSOLE | COM NEW | 1.99M | SH | $12.53M 0.86% | 1.99M | 0.00 | 0.00 |
BAUSCH HEALTH COS INCSOLE | COM | 1.53M | SH | $12.49M 0.86% | 1.53M | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | COM | 869.91K | SH | $12.17M 0.83% | 869.91K | 0.00 | 0.00 |
Page 1 of 3